Partner With Us NRI

Company details

6M Return -24.16%
1Y Return -44.89%
Mkt Cap.(Cr) 3,769.75
Volume 1,900
Div Yield 0.24%
OI Chg %
Volume 1,900

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 913.42 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -38,406.68
LAST 3M 72,017.19 -50,293.88
LAST 6M 138,790.76 -188,500.14
LAST 12M 206,712.84 -177,545.72
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
Feb 09, 2022 Dividend 10
Nov 03, 2020 Dividend 25
Sep 30, 2020 Bonus 3:1


  • About Company
  • Company Info
  • Listing Info
  • Aarti Drugs Ltd is in the Pharmaceuticals sector with the Market Capitalization of worth Rs. 5,768.98 crores, it is incorporated in the year 1984. It features consolidated sales of Rs. 579.95 crores in June 2021. It is also listed in the Bombay Stock Exchange (BSE) with the code 524348 and listed in the National Stock Exchange (NSE) with the code AARTIDRUGS.

    Aarti Drugs Ltd was incorporated as a private limited company on 28th September ’1984 and converted into a public limited company in 1992. It is owned by Aarti Industries Ltd, which also owns a Research & Development plant in Tarapur, Maharashtra. The Company is engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and produces Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited. The Company operates through eight manufacturing facilities, two of which are strategically located in the state of Gujarat and Maharashtra. Also, all the manufacturing units of Aarti Industries are GMP certified, and therefore, the Company is additionally in the process of acquiring certification as per ISO 9002 compliance standard for all its units, out of which one has received the certification. The promoters of the Company currently hold 60.14% of the stake in the Company, while the Foreign Institutional Investors (FII) and Domestic Institutional Investors (DII) hold 2.57% and 2% of the stake. The balance of 35.29% is held by others (retail investors).

    In June 2021, quarterly net sales were Rs. 505.79 crores, which has increased by approximately 6.36% from Rs. 475.55 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 45.54 crores, which has fallen by 37.64% from a net profit of Rs. 73.03 crores in June 2020. In June 2021, the operating profit was Rs. 429.79 crores, which is also increased by 3.51% as compared to the operating profit of Rs. 415.22 crores for the quarter ending in June 2020. From Rs. 31.34 in June 2020, the EPS of Aarti Drugs has been reduced to just Rs. 4.9 per share in June 2021. AARTIDRUGS’s stock closed at Rs. 634.80 on 16th August’2021 (NSE) and has returned -1.50% in the last six months and -70.23% in the last year.

Read More

Registered Address

Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal, Thane, Maharashtra, 401506

Tel : 91-22-24072249
Email : investorrelations:aartidrugs.com
Website : http://www.aartidrugs.com


Sharepro Services

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524348
Book Closure Date (Month) :
BSE Group : A
ISIN : INE767A01016

ICICIdirect Aarti Drugs Ltd FAQ

You can buy Aarti Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aarti Drugs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 25, 2022 01:10 PM the closing price of Aarti Drugs Ltd was ₹ 407.10.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 25, 2022 01:10 PM, the market cap of Aarti Drugs Ltd stood at ₹ 3,769.75.
The latest PE ratio of Aarti Drugs Ltd as of May 25, 2022 01:10 PM is 18.89
The latest PB ratio of Aarti Drugs Ltd as of May 25, 2022 01:10 PM is 0.27
The 52-week high of Aarti Drugs Ltd is ₹ 778.15 while the 52-week low is ₹ 402.90 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote